1-4 of 4
Toshiyuki Tsukaguchi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer

Hiroshi Tanaka, Hitoshi Sase, Toshiyuki Tsukaguchi, Masami Hasegawa, Hiromi Tanimura, Miyuki Yoshida, Kiyoaki Sakata, Toshihiko Fujii, Yukako Tachibana, Kenji Takanashi, Atsuko Higashida, Kiyoshi Hasegawa, Yoshiyuki Ono, Nobuhiro Oikawa, Toshiyuki Mio
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (12): 2519–2529.
https://doi.org/10.1158/1535-7163.MCT-17-1180
Published: 03 December 2018
View article titled, Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
Open the PDF for Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer in another window
Includes: Supplementary data
Journal Articles

Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3–BAIAP2L1

Yoshito Nakanishi, Nukinori Akiyama, Toshiyuki Tsukaguchi, Toshihiko Fujii, Yasuko Satoh, Nobuya Ishii, Masahiro Aoki
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2015) 14 (3): 704–712.
https://doi.org/10.1158/1535-7163.MCT-14-0927-T
Published: 09 March 2015
View article titled, Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3–BAIAP2L1
Open the PDF for Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3–BAIAP2L1 in another window
Includes: Supplementary data
Journal Articles

Alectinib Shows Potent Antitumor Activity against RET-Rearranged Non–Small Cell Lung Cancer

Tatsushi Kodama, Toshiyuki Tsukaguchi, Yasuko Satoh, Miyuki Yoshida, Yoshiaki Watanabe, Osamu Kondoh, Hiroshi Sakamoto
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (12): 2910–2918.
https://doi.org/10.1158/1535-7163.MCT-14-0274
Published: 04 December 2014
View article titled, Alectinib Shows Potent Antitumor Activity against <em>RET</em>-Rearranged Non–Small Cell Lung Cancer
Open the PDF for Alectinib Shows Potent Antitumor Activity against <em>RET</em>-Rearranged Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor

Yoshito Nakanishi, Nukinori Akiyama, Toshiyuki Tsukaguchi, Toshihiko Fujii, Kiyoaki Sakata, Hitoshi Sase, Takehito Isobe, Kenji Morikami, Hidetoshi Shindoh, Toshiyuki Mio, Hirosato Ebiike, Naoki Taka, Yuko Aoki, Nobuya Ishii
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (11): 2547–2558.
https://doi.org/10.1158/1535-7163.MCT-14-0248
Published: 03 November 2014
View article titled, The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor
Open the PDF for The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor in another window
Includes: Supplementary data